Swiss National Bank »

Celldex Therapeutics shares owned by Swiss National Bank

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8M 114k 41.97
2023-12-31 $3.8M 97k 39.66
2023-09-30 $2.4M 88k 27.52
2023-06-30 $3.0M 87k 33.93
2023-03-31 $2.9M 81k 35.98
2022-12-31 $4.0M 90k 44.57
2022-09-30 $2.5M 88k 28.11
2022-06-30 $2.4M 88k 26.96
2022-03-31 $3.0M 88k 34.06
2021-12-31 $3.2M 82k 38.64
2021-09-30 $4.6M 85k 53.99
2021-06-30 $2.9M 87k 33.44
2021-03-31 $1.9M 90k 20.60
2020-12-31 $1.6M 89k 17.53